"Mácula D&T esta dedicado a la prestación de servicios de diagnóstico, tratamiento y cirugía de alta complejidad en las diferentes patologías oftalmológicas. Contamos con equipos biomédicos de última generación y con un selecto staff de médicos con las sub especialidades de segmento anterior y posterior altamente reconocidos en el país y en el extranjero. Tenemos convenios con las más renombradas Compañías de Seguros y Autoseguros; así como con Entidades del Estado. Adiconalmente contamos con la primera historia clínica electrónica Internacional en Oftalmología (IFA) en el Perú."

During the past decade, Mácula D&T conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mácula D&T" are "Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Mácula D&T" in a lesser frequency.

Most popular intervention types in "Mácula D&T" are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Lampalizumab" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mácula D&T" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mácula D&T". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mácula D&T, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mácula D&T, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".